DALLAS–(BUSINESS WIRE)–For the next 30 days, Susan G. Komen, the Milburn Foundation and
the Inflammatory Breast Cancer Research Foundation (IBCRF) are joining
forces to give donors a chance to double their donation and help fuel
research into one of the most aggressive forms of breast cancer. Through
the end of the month, Milburn and IBCRF will match all donations to
Komen up to $50,000, raising up to $100,000 in funds for research aimed
at finding new ways of detecting and treating inflammatory breast cancer
“IBC is often difficult to diagnose because it does not usually present
with a lump. Its main symptoms are redness, swelling or a rash, and many
physicians aren’t familiar with this less common type of breast cancer,”
said Victoria Wolodzko, VP of Research and Community Health Program
Operations at Komen. “This is particularly alarming because it means
women with IBC are being diagnosed at advanced stages, when there are
not as many treatment options and odds of survival are lower.”
Research breakthroughs for aggressive forms of breast cancer, including
IBC, are central to Komen’s Bold Goal of reducing the current number of
breast cancer deaths in the U.S. by 50 percent by 2026.
“Our partnership with the Milburn Foundation and IBCRF will allow us to
fund research that could lead to more effective treatments for IBC,
pushing us closer to achieving our Bold Goal, and ultimately ending this
disease,” Wolodzko added.
This is the second year that Komen and the Milburn Foundation have
teamed up, raising
more than $409,000 in March of 2016 (more than eight times the
matching gift goal). In addition, Komen, Milburn and IBCRF teamed up
last fall to announce
funding for two grants aimed at developing new ways of diagnosing
and treating IBC.
“We are ardent supporters of Susan G. Komen’s Bold Goal,” said Bryon
Davis, President of the Milburn Foundation. “This fund-raising
initiative and the IBC research grant collaboration, actively
demonstrate how a private foundation like ours can unite leading
partners against a common enemy – breast cancer.”
“Komen is a true leader in the breast cancer space and their dedication
to openness, authentic team work and new approaches is a testament to
the partnership’s success,” Davis continued. “IBCRF’s deep expertise is
integrated in a way that is seamless and amplifies the benefits for all.”
“Tackling the challenge of inflammatory breast cancer (IBC) requires
determination and collaboration,” said Ginny Mason, RN, IBC Survivor and
Executive Director of IBCRF.
“Research has been the focus of our mission from day one, and we’re
delighted to continue working with the Milburn Foundation and Komen,”
Mason shared. “We see this matching gift campaign as both an IBC
educational opportunity and a way to engage support for research of
aggressive breast cancers like IBC.”
The largest nonprofit funder of breast cancer research outside of the
federal government, Komen has invested $8.9 million into research
focused on IBC to date – part of the organization’s $920 million
research portfolio. Read
more about Komen’s research programs.
About Susan G. Komen®
Susan G. Komen is the world’s largest breast cancer organization,
funding more breast cancer research than any other nonprofit outside of
the federal government while providing real-time help to those facing
the disease. Komen has set a Bold Goal to reduce the current number of
breast cancer deaths by 50 percent in the U.S. by 2026. Since its
founding in 1982, Komen has funded more than $920 million in research
and provided more than $2 billion in funding to screening, education,
treatment and psychosocial support programs serving millions of people
in more than 30 countries worldwide. Komen was founded by Nancy G.
Brinker, who promised her sister, Susan G. Komen, that she would end the
disease that claimed Suzy’s life. Visit komen.org
or call 1-877 GO KOMEN. Connect with us on social at ww5.komen.org/social.
About The Milburn Foundation
The Milburn Foundation structures creative partnerships with public
charities and companies to drive philanthropic innovation for targeted
causes. Large or small companies interested in inventive Corporate
Social Responsibility (CSR) solutions may have an opportunity to double
or triple their impact through our programs. The Milburn Foundation is
the proud recipient of the 2016 Susan G. Komen Reach Award (for
fundraising innovation) and we are delighted to join the ranks of Conde
Nast and other notable organizations who previously won this award.
Find out more by visiting TheMilburnFoundation.org.
About IBC Research Foundation
Since 1999 the Inflammatory Breast Cancer Research Foundation (IBCRF)
has been leading the way in improving the lives of those touched by
inflammatory breast cancer (IBC) through the power of action and
advocacy. This is accomplished by tenaciously fostering innovative
research, creatively educating stakeholders, and tirelessly advocating
for both current patients and IBC survivors.
As a web-based non-profit, IBCRF relies on its dedicated volunteers
across the country. Guided by the Medical Advisory Board, a group
of extraordinary oncology professionals, IBCRF has funded
patient-focused IBC research resulting in new discoveries as well
as clinical trials. Learn more at www.ibcresearch.org
or call 1-877-stop ibc. On social media? Join us on
Facebook and Twitter (@IBCResearch).
Susan G. Komen
Joni Avery, 972-855-4382